Prof. Dr. med. Jörg F. Debatin, MBA – Innovation Forum 2016 – Leaders Conference Speakers

We are delighted to announce our speakers line-up for the Innovation Forum 2016 conference. Follow us to keep up to date as we introduce our eminent speakers.

Jörg Debatin is the Vice President and Chief Technology and Medical Officer for GE Healthcare, a $17 billion division of General Electric. Jörg is responsible for leading GE Healthcare’s global Technology and Medical Innovation organization, whose research and development teams create and sustain innovative diagnostics, healthcare IT, and life sciences product offerings that reduce healthcare costs, improve healthcare quality, and increase patient access to healthcare globally.

Jorg Debatin
Photo: Prof. Dr. med. Jörg F. Debatin, MBA, Vice President, Chief Technology and Medical Officer, GE Healthcare, GE Corporate Officer

A highly regarded physician and winner of several academic honors and awards, Jörg’s background includes medical diagnostics, leadership of major medical institutions, and extensive experience in magnetic resonance imaging.

Jörg began his career as a diagnostic Radiologist working at Duke, Stanford, and Zurich, Switzerland. He was appointed Professor of Diagnostic Radiology at the University of Essen, Germany in 1999. Jörg’s previous experience also includes eight years as Medical Director & CEO of the University Medical Center, Hamburg-Eppendorf, where he implemented a clear portfolio strategy focusing on complex medicine and established a Comprehensive Cancer Center linking clinical medicine with new oncologic research strategies.

Before joining GE Healthcare, Jörg served as CEO for Amedes AG for three years and led the development of out-patient diagnostic services.
Jörg holds a medical degree from the University of Heidelberg, Germany. He also attained an Executive M.B.A. from Hochschule St. Gallen, Switzerland. Jörg, his wife Amrei and their four sons have relocated from Hamburg, Germany to Wisconsin, USA.

For a complete schedule and to secure your tickets please visit our Innovation Forum 2016 – Leaders Conference page (www.inno-forum.org/conference/)

Markku Markkula – Innovation Forum 2016 – Leaders Conference Speakers

We are delighted to announce our speakers line-up for the Innovation Forum 2016 conference. Follow us to keep up to date as we introduce our eminent speakers.

Drawing from his wealth of knowledge as President of the European Committee of Regions (CoR) and Vice-Chairman of the Open Innovation Strategy and Policy Group (OISPG), Markku Markkula will be presenting a keynote address entitled “Bridging the Innovation Gap in accelerating Economic and Social Development in Europe“. The talk will aim to inform and deliberate over the plans and aims of CoR. What are the driving forces and limiting factors involved in economic and social development? Which policies will strengthen innovation and which will smother it? 

For a complete schedule and to secure your tickets please visit our Innovation Forum 2016 – Leaders Conference page (www.inno-forum.org/conference/)

Markku Markkula
Photo: Markku Markkula, President of the European Committee of the Regions (CoR), European Comission

Markku Markkula was elected President of the European Committee of the Regions (CoR) in February 2015 for a two and a half year term of office. 

Since joining the CoR in 2010 he has held several influential positions such as the first Vice-Chair of the CoR’s EPP Group and Chair of the CoR’s EPP Task Force on Europe 2020. He was the CoR’s rapporteur in the field of innovation for subjects including: “The digital agenda for Europe”, “The role of local and regional authorities in achieving the objectives of the Europe 2020 strategy”, “Enhancing and focusing EU international cooperation in research and innovation”, “Horizon 2020”, “Better governance for the single market”, “Closing the innovation divide”, “Creation of high-tech start-up ecosystems”, and “The industrial policy package”. He has also been a member of several High Level Expert Groups, such as the EU Smart Specialisation Mirror Group. 

He is a member of the National Coalition Party in Finland having held numerous political chairmanships throughout his career starting with the local and national Student Unions in Espoo City and the Uusimaa region and is a long standing member of the Board of the Party. A member of Espoo City Council since 1980, he held its presidency in 1990-92 and 2010. He is currently a member of the Board of Helsinki Regional Council and Chairman of Espoo City Planning Board. 

President Markkula is a former member of the Finnish Parliament (1995-2003). During this time he served as a member of two permanent parliamentary committees: the Committee for Science, Education and Culture, and the Committee for the Future. As an MP his international role included the Presidency of EPTA Council, European Parliamentary Technology Assessment Network. 

Markku Markkula works at Aalto University as the Advisor to Aalto Presidents, where his focus is on European Union research, innovation and education policy affairs. He has previously worked as the Director of the Lifelong Learning Institute Dipoli and the Secretary-General of the International Association for Continuing Engineering Education (IACEE). He has acted as the Chairman of the Board of Laurea University of Applied Sciences and the Chairman of the Society for Organizational Learning (SOL-Finland) and has been the Chairman of the Continuing Education Working Group of SEFI, European Society for Engineering Education. He is one of the Ambassadors of the Leonardo European Corporate Learning Award.

President Markkula has held several important roles related to innovation ecosystems development in Finland, especially in the Helsinki region. For example he is the initiator and orchestrator of the EUR 20m research programme “Energising Urban Ecosystems” and has been involved in several open innovation initiatives related to the Espoo Innovation Garden and Aalto University. 

In Finland his roles have included memberships of the boards of several companies and organisations such as Tekes, the Finnish Funding Agency for Innovation and Technology. He has served as the chairman of the Board of the Finnish Association of Graduate Engineers TEK (1993-2005) and of the Finnish Information Society Development Centre TIEKE (2000-2011). 

As a tribute to his achievements he was elected to the International Adult and Continuing Education Hall of Fame in 2008.

Markku Markkula was born in Kolari (Finland) north of the Arctic Circle on 15 July 1950. He is married with one son and two daughters.

Ruth March, PhD – Innovation Forum 2016 – Leaders Conference Speakers

We are delighted to announce our speakers line-up for the Innovation Forum 2016 conference. Follow us to keep up to date as we introduce our eminent speakers. 

Our opening keynote will be given by Ruth March, vice-president of AstraZeneca’s Personalised Healthcare and Biomarkers function. She will speak on how world-class science is transforming how pharmas do business. Science is enabling healthcare to move away from a “one-size-fits-all” approach to prescription and towards a personalised, precision medicine model. What are the key structural changes that need to be put in place? How and who will adapt?

For a complete schedule and to secure your tickets please visit our Innovation Forum 2016 – Leaders Conference page (www.inno-forum.org/conference/)

Photo: Ruth March, PhD – Vice-President, Personalised Healthcare and Biomarkers at AstraZeneca

Ruth March, PhD, is Vice President of AstraZeneca’s Personalised Healthcare & Biomarkers (PHB) function, which includes more than 100 diagnostic and biomarker experts in the UK, US and Sweden. A member of the senior team leading Innovative Medicines & Early Development, Ruth is accountable for delivering companion diagnostics and validated biomarkers to AstraZeneca drug projects, targeting medicines across all therapy areas to those most likely to benefit. 

Ruth has led development of AstraZeneca’s capability in Personalised Healthcare (PHC), ensuring 80% of drug projects are following a PHC approach, and has enabled regulatory approvals linked to companion diagnostics, including: TAGRISSO (US and EU), LYNPARZA (EU and US), IRESSA (2009, 90 countries and 2015, US) and based on circulating tumour DNA (EU, 2014 and China, 2015).

Ruth pioneered: the first FDA-approved lab-based companion diagnostic, the first drug label based on circulating tumour DNA, the first diagnostic partnership for next generation sequencing, and PHC across therapy areas. She is a member of the Supervisory Board for Definiens, whose software aims to improve treatment in immuno-oncology. A genomics specialist with over 45 publications and patents, her academic research was key to the submission of the first genome-wide SNP analysis of a hepatic adverse event to the FDA.

Interview with Dr Eliot Forster (Immunocore Ltd.)

Dr Eliot Forster joined Immunocore as Chief Executive Officer in January 2015. He has almost 25 years of experience in the pharmaceutical and biotechnology industry. Dr Forster previously served as Chief Executive Officer of Creabilis since 2010 and prior to that role was Chief Executive Officer of US biotechnology company, Solace Pharmaceuticals Inc. His other previous roles include Head of EU Development and Operations for the EU and Asia at Pfizer, where he was responsible for drug development activities across multiple geographies and brought several drugs to market, and Clinical Research Manager at GlaxoSmithKline. Dr Forster is currently Chairman of the MedCity project that aims to grow a world-leading life sciences cluster in the south-east of England. He holds a PhD in neurophysiology from Liverpool University and an MBA from Henley Management College.

ON Helix by One Nucleus

ON Helix is a one-day event by One Nucleus aimed at informing delegates of how to turn early stage inventions and ideas into innovative health treatments (new medicines, novel biomarkers, useful medical devices or improved medical practices).

It will present the UK landscape of the business environment, funding, scientific and clinical research excellence and will be a unique knowledge-sharing environment between academia and business:

  • The Future of Medicines: Do Patients Make the Best Models?
  • The Role of Technology Transfer Offices
  • Funding Early Stages of Translational Medicine

 

Keynote Speakers:


Dr Susan Windham-Bannister
, Former President and CEO of the Massachusetts Life Sciences Center

Dr David Roblin, Chief Operating Officer and Director of Translation at The Francis Crick Institute

Professor Nick Lemoine, Medical Director at the NIHR and Director of Barts Cancer Institute

Professor Sir John Savill, CEO of the Medical Research Council will also be delivering keynote addresses

and VIP Guest of Honour who will be starting the day off.

Click to view the 2016 programme for ON Helix.

The conference will commence with a Welcome Reception and BioNewsRound Awards on 27 June, more information can be found here.

To register, please click here.

Stanford Ignite – London: Turn Ideas into Action

“I’m truly impressed by the quality of the education, the network and the incredible, mission-driven team leading it. Worth every penny and more. I can’t recommend Stanford Ignite more highly.” David Bailey, Innovator & CEO, Stanford Ignite 2015 cohort

 After a highly successful 2015 cohort, the Stanford Graduate School of Business returns to London this autumn with the Stanford Ignite program. Inspired by the academic rigor of Stanford’s highly-competitive MBA and Silicon Valley’s entrepreneurial mindset, Stanford Ignite teaches innovators to formulate, develop and commercialise their ideas. This unique program, taught by world-renown Stanford MBA faculty, incorporates the fundaments of business and the practical aspects of identifying and evaluating business ideas.

“I cannot think of any other programme which would have provided the blend of academic thinking, practical application and overall high quality learning experience like Stanford Ignite. I gained a fantastic network of peers with similar interests along with a 360-degree view of what it means to build a venture from idea generation to execution through to pitching to investors.” Winnie Awa, Digital Programme Manager at ASOS, Stanford Ignite 2015 cohort

 

The 3-month program includes class lectures, coaching sessions, advisory meetings with senior Stanford faculty, and panels discussions with venture capitalists and industry innovators. Participants learn:

  • Core business skills: marketing, operations, strategy, accounting, finance, and economics
  • Applied skills: negotiation, teamwork, public speaking, leadership, and pitching
  • Practical application: immediately apply concepts learned in the classroom to real-world, team-based projects

 

Who Should Attend

The program combines innovators, scientists, and engineers from leading companies with current graduate students and entrepreneurs working in startups or developing new products and services. The program directors and staff focus on building a diverse cohort of participants.

Worldwide Presence

Stanford Ignite is offered on the Stanford campus in Silicon Valley as well as in Bangalore, Beijing, London, New York City, São Paulo, and Santiago. Nearly 40 cohorts have completed the program since its beginning in 2006.

 Dates: 23 September – 4 December 2016
Class sessions are on Friday evening, Saturday, and Sunday over seven non-consecutive weekends.

 Venue: Infosys, Canary Wharf

Instructional Method: A combination of lectures, case evaluations, small group discussions, workshops, panels, and team projects.

Certification: Upon completion of the program, participants will receive an official certificate from Stanford Graduate School of Business.

 Application Deadlines:

            Round 1: 2 June*

            Round 2: 16 June

 

Start your application here.

 

Visit the website for more information

 

*Applicants must apply by the Round 1 deadline to be considered for a 50% scholarship.

IMAGINE IF! building science startups was easy?

Registration for the IMAGINE IF! Accelerator is now open!

IMAGINE IF! is the first truly global competition and accelerator program for deep technology organised by the Innovation Forum across our global branches. If you have a science-based idea, you can participate in our workshops, open networking events and pitching sessions with top players in the local and global enterprise ecosystem. The best 15 global teams will pitch at the Innovation Forum – Leaders Conference 2016 in Cambridge (UK).

How does it work?

Local Innovation Forum branches will organize a pre-acceleration program of workshops during the month of June. By the end of the program all teams should have a stronger business plan and pitch in front of the local Dragons’ Den panel. The best teams from the local competition will enter the global IMAGINE IF! where they’ll receive training from the the best international experts and seasoned entrepreneurs.

Apply to IMAGINE IF! and get:

  • Tailored workshops 
  • Mentoring from top local and international industry leaders
  • FREE trip to Cambridge to meet the industry leaders
  • Pitch in front of leading European investors
  • 30.000 USD in prizes
  • The chance to improve the world through scientific innovation!

Workshops will cover:

  • How to pitch your business idea 
  • Alternative financing
  • Development of an effective business plan
  • Intelectual property 
  • and more!

Check out the website to meet our mentors and learn more about the program. The participation is free, don’t miss this opportunity!

Registration deadline for local finals will vary. If you miss your local deadline you can still apply through the independent stream by the 1st of July 2016

Questions? Contact us at [email protected]

 

 

 

Leaders Conference 2016 – REGISTER NOW!

The annual flagship event of the Innovation Forum ‐ Leaders Conference 2016 (IF2016) is on sale now!

On the 21-22 September, we will bring together as many as 600 delegates: CEOs, prominent investors and top innovators to head discussions of the latest trends in therapeutics, cleantech and medtech. 

Whether  you  are  an  industry  leader,  investor,  leading academic  or  early‐stage  entrepreneur,  IF2016  offers  you the  chance to benefit from extensive partnering opportunities, hear  key  opinions, discuss the latest  trends  in  innovation and find  inspiration.  Find out what’s on the agenda.

The event will also host the Grand Finale of IMAGINE IF! – the global competition & accelerator for deep technology startups. 

Tickets will sell fast. Get yours while you still can!